New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
07:14 EDTEL, ELEstee Lauder downgraded to Outperform from Buy at CLSA
CLSA downgraded Estee Lauder citing reduced organic sales growth following yesterday's weaker than expected U.S. retails sales for December. Price target remains $74.
News For EL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 7, 2015
12:36 EDTELYum! results may be 'bad harbinger' for Estee Lauder, says Jefferies
Jefferies analyst Kevin Grundy says his analysis suggests a 60% correlation between Estee Lauder's (EL) sales in China and Yum! Brands' (YUM) same-store-sales. Yum!'s weak China results last night "should not be easily dismissed" and may be a "bard harbinger" for Estee Lauder's quarter, Grundy tells investors in a research note. He keeps a Hold rating on Estee Lauder with Yum! shares down 18% after its weaker than expected Q3 results.
12:31 EDTELNu Skin plummets after cutting Q3 revenue outlook
Shares of Nu Skin (NUS), a global direct selling company, are sinking after the company lowered its third quarter revenue outlook. WHAT'S NEW: Tuesday after the bell, Nu Skin lowered its Q3 revenue view to $570M-$573M from $600M-$620M, well below analysts' consensus estimates of $621.55M. Foreign currency headwinds associated with the strengthening of the U.S. dollar negatively impacted revenue by more than $60M compared to the prior-year period. The revised revenue range is expected to represent continued improvement on a sequential basis, and the company continues to forecast constant-currency revenue growth in the fourth quarter of 2015 versus the prior year. WHAT'S NOTABLE: Truman Hunt, Nu Skin's Chief Executive Officer, noted, "Third quarter results were impacted by lower-than-expected sales of our new cosmetic oils in China during August and September, which may be a reflection of economic conditions in China." Hunt continued, "Our third quarter results will be in-line with expectations, with the exception of the Greater China region. Revenue growth in the third quarter was particularly strong in South Asia/Pacific, where our first introduction of ageLOC Youth drove more than 20% growth in that region, or more than 40% on a constant-currency basis. Given the successful launch of ageLOC Youth in South Asia/Pacific, we look forward to the introduction of ageLOC Youth as well as ageLOC Me in most of our regions during the fourth quarter. We forecast year-over-year constant-currency revenue growth of between 7%-10% in the fourth quarter." ANALYST REACTION: Sentiment on the Street was cautious at midday. Research firm Stifel downgraded Nu Skin to Sell from Hold, citing the company's negative pre-announcement and its deteriorating trends in Greater China. Its price target for shares is $35. Another firm, Canaccord, noted that NuSkin pre-announced revenue numbers that were below guidance, which suggests softer trends in China and the long awaited sustainable turn in momentum has failed to materialize. The firm expects a new product cycle to help support the return to growth. Canaccord maintained its Hold rating and lowered its price target to $45 from $48 on NuSkin shares. PRICE ACTION: In midday trading, Nu Skin fell $12.13, or about 26%, to $34.45 on about six times its average daily trading volume. OTHERS TO WATCH: Other companies in the direct selling business include Herbalife (HLF), down 9.2%, Estee Lauder (EL), down fractionally, USANA Health Sciences (USNA) down 8.4%, Avon Products (AVP) up almost 8%, and Tupperware Brands (TUP), up 2.5%.
September 28, 2015
10:00 EDTELOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:58 EDTELEstee Lauder initiated with a Hold at Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use